Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study

被引：0
|
作者：
C Hanotin
F Thomas
SP Jones
E Leutenegger
P Drouin
机构：
[1] Laboratoires Knoll France,Department of Clinical Research
[2] Knoll Pharmaceuticals,Department of Clinical Research
[3] Service de Diabétologie,undefined
[4] Maladies Métaboliques et Nutrition,undefined
[5] CHU de Nancy,undefined
[6] Hôpital Jeanne d'Arc,undefined
来源：
International Journal of Obesity | 1998年 / 22卷
关键词：
obesity; weight loss; sibutramine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
OBJECTIVES: To assess the weight-reducing effects and tolerability of 5 mg, 10 mg and 15 mg daily doses of sibutramine, a novel serotonin and noradrenaline reuptake inhibitor (SNRI).
引用
收藏
页码：32 / 38
页数：6
相关论文
共 50 条
  • [31] Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies
    Ryan, CW
    Vogelzang, NJ
    Vokes, EE
    Kindler, HL
    Undevia, SD
    Humerickhouse, R
    André, AK
    Wang, Q
    Carr, RA
    Ratain, MJ
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4406 - 4411
  • [32] Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
    Noonan, Michael
    Korenblat, Phillip
    Mosesova, Sofia
    Scheerens, Heleen
    Arron, Joseph R.
    Zheng, Yanan
    Putnam, Wendy S.
    Parsey, Merdad V.
    Bohen, Sean P.
    Matthews, John G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (03) : 567 - +
  • [33] A phase II dose-ranging study of mirabegron in patients with overactive bladder
    Chapple, Christopher R.
    Dvorak, Vladimir
    Radziszewski, Pjotr
    Van Kerrebroeck, Philip
    Wyndaele, Jean Jacques
    Bosman, Brigitte
    Boerrigter, Peter
    Drogendijk, Ted
    Ridder, Arwin
    Van der Putten-Slob, Ingrid
    Yamaguchi, Osamu
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 (09) : 1447 - 1458
  • [34] BIVARIATE BINARY MODELS OF EFFICACY AND TOXICITY IN DOSE-RANGING TRIALS
    MURTAUGH, PA
    FISHER, LD
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1990, 19 (06) : 2003 - 2020
  • [35] Safety and efficacy of a novel extended release formulation of metformin in patients with type 2 diabetes: A dose-ranging study
    Brazg, R
    Decherney, S
    Proszynski, E
    Holland-O'Rourke, D
    Goyvaerts, H
    Pans, M
    Stein, P
    DIABETES, 2000, 49 : A99 - A99
  • [36] Efficacy and safety of dapagliflozin in a dose-ranging monotherapy study of treatment-naive patients with type 2 diabetes
    List, J. F.
    Woo, V.
    Morales, E.
    Tang, W.
    Fiedorek, F. T.
    DIABETOLOGIA, 2008, 51 : S22 - S23
  • [37] The safety and efficacy of a combination of extended-release niacin and sirinvastatin in patients with dyslipidemia (SEACOAST): A dose-ranging study
    Ballantyne, Christie
    Davidson, Michael
    McKenney, James
    Keller, Laurence H.
    Bajorunas, Daiva R.
    Karas, Richard H.
    CIRCULATION, 2007, 116 (16) : 15 - 16
  • [38] Efficacy and safety of dapagliflozin in a dose-ranging monotherapy study of treatment-naive patients with type 2 diabetes
    List, James F.
    Woo, Vincent C.
    Villegas, Enrique Morales
    Tang, Weihua
    Fiedorek, Fred T.
    DIABETES, 2008, 57 : A94 - A94
  • [39] Efficacy and safety of conivaptan in acute decompensated heart failure: A dose-ranging pilot study
    Goldsmith, Steven R.
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S72 - S72
  • [40] EFFICACY OF BETAXOLOL IN THE TREATMENT OF STABLE EXERTIONAL ANGINA-PECTORIS - A DOSE-RANGING STUDY
    ALPERT, MA
    MUKERJI, V
    VILLARREAL, D
    SINGH, A
    FLAKER, GC
    SANFELIPPO, JF
    BEACH, CL
    MORGAN, RJ
    ANGIOLOGY, 1990, 41 (05) : 365 - 376
12345